BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3887374)

  • 1. Haemodialysis with prostacyclin (Epoprostenol) alone.
    Rylance PB; Gordge MP; Ireland H; Lane DA; Weston MJ
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():281-6. PubMed ID: 3887374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodialysis without heparin.
    Woods HF; Weston MJ; Bunting S
    Proc Eur Dial Transplant Assoc; 1978; 15():122-9. PubMed ID: 368769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostacyclin and heparin during haemodialysis: comparative effects.
    Camici M; Evangelisti L
    Life Support Syst; 1986; 4(3):205-9. PubMed ID: 3537544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of prostacyclin infusion on haemodialysis efficiency and blood cells.
    Kuźniewski M; Sułowicz W
    Int Urol Nephrol; 1992; 24(5):555-63. PubMed ID: 1459834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of heparin and prostacyclin-heparin infusion on blood coagulation in haemodialysed patients.
    Kuźniewski M; Sułowicz W; Lisiewicz J
    Int Urol Nephrol; 1991; 23(1):89-96. PubMed ID: 1938222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration.
    Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M
    Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal left ventricular assistance with prostacyclin and heparinized centrifugal pump.
    Palatianos GM; Edmunds LH; Cohen DJ; Stephenson LW
    Ann Thorac Surg; 1983 May; 35(5):504-15. PubMed ID: 6342555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostacyclin safer than heparin in haemodialysis.
    Arze RS; Ward MK
    Lancet; 1981 Jul; 2(8236):50. PubMed ID: 6113427
    [No Abstract]   [Full Text] [Related]  

  • 9. Epoprostenol (PGI2, prostacyclin) during high-risk hemodialysis: preventing further bleeding complications.
    Swartz RD; Flamenbaum W; Dubrow A; Hall JC; Crow JW; Cato A
    J Clin Pharmacol; 1988 Sep; 28(9):818-25. PubMed ID: 3068260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased platelet sensitivity to prostacyclin (epoprostenol) during hemodialysis.
    Kristensen SD; Knudsen F; Nielsen AH; Ring T
    Clin Nephrol; 1984 Apr; 21(4):230-4. PubMed ID: 6375926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet protection and heparin sparing with prostacyclin during regular dialysis therapy.
    Turney JH; Williams LC; Fewell MR; Parsons V; Weston MJ
    Lancet; 1980 Aug; 2(8188):219-22. PubMed ID: 6105392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent.
    Zusman RM; Rubin RH; Cato AE; Cocchetto DM; Crow JW; Tolkoff-Rubin N
    N Engl J Med; 1981 Apr; 304(16):934-9. PubMed ID: 7010166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute renal and hepatic failure.
    Davenport A; Will EJ; Davison AM
    Nephron; 1994; 66(4):431-7. PubMed ID: 8015647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prostacyclin versus regional heparinisation during haemodialysis (author's transl)].
    Hory B; Saunier F; Roy C; Renevier A; Kieffer Y; Saint-Hillier Y; Perol C
    Nouv Presse Med; 1982 Jul 10-17; 11(32):2393-7. PubMed ID: 7050907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the effectiveness of hemodialysis using only heparin or prostacyclin with heparin].
    Kuźniewski M; Sułowicz W
    Przegl Lek; 1990; 47(3):328-31. PubMed ID: 2236625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostacyclin infusion during extracorporeal circulation foe coronary bypass.
    Rådegran K; Arén C; Teger-Nilsson AC
    J Thorac Cardiovasc Surg; 1982 Feb; 83(2):205-11. PubMed ID: 7035754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a stable 5-F prostacyclin analogue as an antithrombotic agent in haemodialysis.
    Nicholson NS; Smith SL; Taite BB; Krueger A; Fuller GC
    Drugs Exp Clin Res; 1986; 12(5):371-5. PubMed ID: 3522158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled study of heparin versus epoprostenol sodium (prostacyclin) as the sole anticoagulant for chronic hemodialysis.
    Caruana RJ; Smith MC; Clyne D; Crow JW; Zinn JM; Diehl JH
    Blood Purif; 1991; 9(5-6):296-304. PubMed ID: 1819317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of coagulation during hemodialysis by a combination of the stable prostacyclin analogue CG 4203 and low-dose heparin.
    Maurin N; Ballmann M
    Clin Nephrol; 1988 Jul; 30(1):35-41. PubMed ID: 3061692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with prostacyclin in cardiopulmonary bypass in dog and man.
    Longmore DB
    Philos Trans R Soc Lond B Biol Sci; 1981 Aug; 294(1072):399-412. PubMed ID: 6117901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.